Global Japanese Encephalitis Vaccines Market Growth 2025-2031
The global Japanese Encephalitis Vaccines market size is predicted to grow from US$ 237 million in 2025 to US$ 326 million in 2031; it is expected to grow at a CAGR of 5.4% from 2025 to 2031.
The impact of the latest U.S. tariff measures and the corresponding policy responses from countries worldwide on market competitiveness, regional economic performance, and supply chain configurations will be comprehensively evaluated in this report.
Epidemic encephalitis (JE) is a disease spreads through mosquito bites. Symptoms usually take 5-15 days to develop and include fever, headache, vomiting, confusion, and difficulty moving. The major form of the disease is encephalitis, and less severe forms such as aseptic meningitis or simple fever syndrome with headache are also frequent. The mortality rate of Japanese encephalitis is high, and sequelae are very common, especially among children (up to 50%). Prevention is possible through the use of inactivated vaccines.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
LP Information, Inc. (LPI) ' newest research report, the “Japanese Encephalitis Vaccines Industry Forecast” looks at past sales and reviews total world Japanese Encephalitis Vaccines sales in 2024, providing a comprehensive analysis by region and market sector of projected Japanese Encephalitis Vaccines sales for 2025 through 2031. With Japanese Encephalitis Vaccines sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Japanese Encephalitis Vaccines industry.
This Insight Report provides a comprehensive analysis of the global Japanese Encephalitis Vaccines landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Japanese Encephalitis Vaccines portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Japanese Encephalitis Vaccines market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Japanese Encephalitis Vaccines and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Japanese Encephalitis Vaccines.
This report presents a comprehensive overview, market shares, and growth opportunities of Japanese Encephalitis Vaccines market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
What is the 10-year outlook for the global Japanese Encephalitis Vaccines market?
What factors are driving Japanese Encephalitis Vaccines market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Japanese Encephalitis Vaccines market opportunities vary by end market size?
How does Japanese Encephalitis Vaccines break out by Type, by Application?
The impact of the latest U.S. tariff measures and the corresponding policy responses from countries worldwide on market competitiveness, regional economic performance, and supply chain configurations will be comprehensively evaluated in this report.
Epidemic encephalitis (JE) is a disease spreads through mosquito bites. Symptoms usually take 5-15 days to develop and include fever, headache, vomiting, confusion, and difficulty moving. The major form of the disease is encephalitis, and less severe forms such as aseptic meningitis or simple fever syndrome with headache are also frequent. The mortality rate of Japanese encephalitis is high, and sequelae are very common, especially among children (up to 50%). Prevention is possible through the use of inactivated vaccines.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
LP Information, Inc. (LPI) ' newest research report, the “Japanese Encephalitis Vaccines Industry Forecast” looks at past sales and reviews total world Japanese Encephalitis Vaccines sales in 2024, providing a comprehensive analysis by region and market sector of projected Japanese Encephalitis Vaccines sales for 2025 through 2031. With Japanese Encephalitis Vaccines sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Japanese Encephalitis Vaccines industry.
This Insight Report provides a comprehensive analysis of the global Japanese Encephalitis Vaccines landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Japanese Encephalitis Vaccines portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Japanese Encephalitis Vaccines market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Japanese Encephalitis Vaccines and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Japanese Encephalitis Vaccines.
This report presents a comprehensive overview, market shares, and growth opportunities of Japanese Encephalitis Vaccines market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
- Attenuated Vaccines
- Inactivated Vaccines
- Adults
- Children
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Sanofi Pasteur
- GlaxoSmithKline
- Bharat Biotech
- China National Biotec Group
- Valneva Products
What is the 10-year outlook for the global Japanese Encephalitis Vaccines market?
What factors are driving Japanese Encephalitis Vaccines market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Japanese Encephalitis Vaccines market opportunities vary by end market size?
How does Japanese Encephalitis Vaccines break out by Type, by Application?
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Japanese Encephalitis Vaccines Annual Sales 2020-2031
2.1.2 World Current & Future Analysis for Japanese Encephalitis Vaccines by Geographic Region, 2020, 2024 & 2031
2.1.3 World Current & Future Analysis for Japanese Encephalitis Vaccines by Country/Region, 2020, 2024 & 2031
2.2 Japanese Encephalitis Vaccines Segment by Type
2.2.1 Attenuated Vaccines
2.2.2 Inactivated Vaccines
2.3 Japanese Encephalitis Vaccines Sales by Type
2.3.1 Global Japanese Encephalitis Vaccines Sales Market Share by Type (2020-2025)
2.3.2 Global Japanese Encephalitis Vaccines Revenue and Market Share by Type (2020-2025)
2.3.3 Global Japanese Encephalitis Vaccines Sale Price by Type (2020-2025)
2.4 Japanese Encephalitis Vaccines Segment by Application
2.4.1 Adults
2.4.2 Children
2.5 Japanese Encephalitis Vaccines Sales by Application
2.5.1 Global Japanese Encephalitis Vaccines Sale Market Share by Application (2020-2025)
2.5.2 Global Japanese Encephalitis Vaccines Revenue and Market Share by Application (2020-2025)
2.5.3 Global Japanese Encephalitis Vaccines Sale Price by Application (2020-2025)
3 GLOBAL BY COMPANY
3.1 Global Japanese Encephalitis Vaccines Breakdown Data by Company
3.1.1 Global Japanese Encephalitis Vaccines Annual Sales by Company (2020-2025)
3.1.2 Global Japanese Encephalitis Vaccines Sales Market Share by Company (2020-2025)
3.2 Global Japanese Encephalitis Vaccines Annual Revenue by Company (2020-2025)
3.2.1 Global Japanese Encephalitis Vaccines Revenue by Company (2020-2025)
3.2.2 Global Japanese Encephalitis Vaccines Revenue Market Share by Company (2020-2025)
3.3 Global Japanese Encephalitis Vaccines Sale Price by Company
3.4 Key Manufacturers Japanese Encephalitis Vaccines Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Japanese Encephalitis Vaccines Product Location Distribution
3.4.2 Players Japanese Encephalitis Vaccines Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR JAPANESE ENCEPHALITIS VACCINES BY GEOGRAPHIC REGION
4.1 World Historic Japanese Encephalitis Vaccines Market Size by Geographic Region (2020-2025)
4.1.1 Global Japanese Encephalitis Vaccines Annual Sales by Geographic Region (2020-2025)
4.1.2 Global Japanese Encephalitis Vaccines Annual Revenue by Geographic Region (2020-2025)
4.2 World Historic Japanese Encephalitis Vaccines Market Size by Country/Region (2020-2025)
4.2.1 Global Japanese Encephalitis Vaccines Annual Sales by Country/Region (2020-2025)
4.2.2 Global Japanese Encephalitis Vaccines Annual Revenue by Country/Region (2020-2025)
4.3 Americas Japanese Encephalitis Vaccines Sales Growth
4.4 APAC Japanese Encephalitis Vaccines Sales Growth
4.5 Europe Japanese Encephalitis Vaccines Sales Growth
4.6 Middle East & Africa Japanese Encephalitis Vaccines Sales Growth
5 AMERICAS
5.1 Americas Japanese Encephalitis Vaccines Sales by Country
5.1.1 Americas Japanese Encephalitis Vaccines Sales by Country (2020-2025)
5.1.2 Americas Japanese Encephalitis Vaccines Revenue by Country (2020-2025)
5.2 Americas Japanese Encephalitis Vaccines Sales by Type (2020-2025)
5.3 Americas Japanese Encephalitis Vaccines Sales by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Japanese Encephalitis Vaccines Sales by Region
6.1.1 APAC Japanese Encephalitis Vaccines Sales by Region (2020-2025)
6.1.2 APAC Japanese Encephalitis Vaccines Revenue by Region (2020-2025)
6.2 APAC Japanese Encephalitis Vaccines Sales by Type (2020-2025)
6.3 APAC Japanese Encephalitis Vaccines Sales by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Japanese Encephalitis Vaccines by Country
7.1.1 Europe Japanese Encephalitis Vaccines Sales by Country (2020-2025)
7.1.2 Europe Japanese Encephalitis Vaccines Revenue by Country (2020-2025)
7.2 Europe Japanese Encephalitis Vaccines Sales by Type (2020-2025)
7.3 Europe Japanese Encephalitis Vaccines Sales by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Japanese Encephalitis Vaccines by Country
8.1.1 Middle East & Africa Japanese Encephalitis Vaccines Sales by Country (2020-2025)
8.1.2 Middle East & Africa Japanese Encephalitis Vaccines Revenue by Country (2020-2025)
8.2 Middle East & Africa Japanese Encephalitis Vaccines Sales by Type (2020-2025)
8.3 Middle East & Africa Japanese Encephalitis Vaccines Sales by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Japanese Encephalitis Vaccines
10.3 Manufacturing Process Analysis of Japanese Encephalitis Vaccines
10.4 Industry Chain Structure of Japanese Encephalitis Vaccines
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Japanese Encephalitis Vaccines Distributors
11.3 Japanese Encephalitis Vaccines Customer
12 WORLD FORECAST REVIEW FOR JAPANESE ENCEPHALITIS VACCINES BY GEOGRAPHIC REGION
12.1 Global Japanese Encephalitis Vaccines Market Size Forecast by Region
12.1.1 Global Japanese Encephalitis Vaccines Forecast by Region (2026-2031)
12.1.2 Global Japanese Encephalitis Vaccines Annual Revenue Forecast by Region (2026-2031)
12.2 Americas Forecast by Country (2026-2031)
12.3 APAC Forecast by Region (2026-2031)
12.4 Europe Forecast by Country (2026-2031)
12.5 Middle East & Africa Forecast by Country (2026-2031)
12.6 Global Japanese Encephalitis Vaccines Forecast by Type (2026-2031)
12.7 Global Japanese Encephalitis Vaccines Forecast by Application (2026-2031)
13 KEY PLAYERS ANALYSIS
13.1 Sanofi Pasteur
13.1.1 Sanofi Pasteur Company Information
13.1.2 Sanofi Pasteur Japanese Encephalitis Vaccines Product Portfolios and Specifications
13.1.3 Sanofi Pasteur Japanese Encephalitis Vaccines Sales, Revenue, Price and Gross Margin (2020-2025)
13.1.4 Sanofi Pasteur Main Business Overview
13.1.5 Sanofi Pasteur Latest Developments
13.2 GlaxoSmithKline
13.2.1 GlaxoSmithKline Company Information
13.2.2 GlaxoSmithKline Japanese Encephalitis Vaccines Product Portfolios and Specifications
13.2.3 GlaxoSmithKline Japanese Encephalitis Vaccines Sales, Revenue, Price and Gross Margin (2020-2025)
13.2.4 GlaxoSmithKline Main Business Overview
13.2.5 GlaxoSmithKline Latest Developments
13.3 Bharat Biotech
13.3.1 Bharat Biotech Company Information
13.3.2 Bharat Biotech Japanese Encephalitis Vaccines Product Portfolios and Specifications
13.3.3 Bharat Biotech Japanese Encephalitis Vaccines Sales, Revenue, Price and Gross Margin (2020-2025)
13.3.4 Bharat Biotech Main Business Overview
13.3.5 Bharat Biotech Latest Developments
13.4 China National Biotec Group
13.4.1 China National Biotec Group Company Information
13.4.2 China National Biotec Group Japanese Encephalitis Vaccines Product Portfolios and Specifications
13.4.3 China National Biotec Group Japanese Encephalitis Vaccines Sales, Revenue, Price and Gross Margin (2020-2025)
13.4.4 China National Biotec Group Main Business Overview
13.4.5 China National Biotec Group Latest Developments
13.5 Valneva Products
13.5.1 Valneva Products Company Information
13.5.2 Valneva Products Japanese Encephalitis Vaccines Product Portfolios and Specifications
13.5.3 Valneva Products Japanese Encephalitis Vaccines Sales, Revenue, Price and Gross Margin (2020-2025)
13.5.4 Valneva Products Main Business Overview
13.5.5 Valneva Products Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Japanese Encephalitis Vaccines Annual Sales 2020-2031
2.1.2 World Current & Future Analysis for Japanese Encephalitis Vaccines by Geographic Region, 2020, 2024 & 2031
2.1.3 World Current & Future Analysis for Japanese Encephalitis Vaccines by Country/Region, 2020, 2024 & 2031
2.2 Japanese Encephalitis Vaccines Segment by Type
2.2.1 Attenuated Vaccines
2.2.2 Inactivated Vaccines
2.3 Japanese Encephalitis Vaccines Sales by Type
2.3.1 Global Japanese Encephalitis Vaccines Sales Market Share by Type (2020-2025)
2.3.2 Global Japanese Encephalitis Vaccines Revenue and Market Share by Type (2020-2025)
2.3.3 Global Japanese Encephalitis Vaccines Sale Price by Type (2020-2025)
2.4 Japanese Encephalitis Vaccines Segment by Application
2.4.1 Adults
2.4.2 Children
2.5 Japanese Encephalitis Vaccines Sales by Application
2.5.1 Global Japanese Encephalitis Vaccines Sale Market Share by Application (2020-2025)
2.5.2 Global Japanese Encephalitis Vaccines Revenue and Market Share by Application (2020-2025)
2.5.3 Global Japanese Encephalitis Vaccines Sale Price by Application (2020-2025)
3 GLOBAL BY COMPANY
3.1 Global Japanese Encephalitis Vaccines Breakdown Data by Company
3.1.1 Global Japanese Encephalitis Vaccines Annual Sales by Company (2020-2025)
3.1.2 Global Japanese Encephalitis Vaccines Sales Market Share by Company (2020-2025)
3.2 Global Japanese Encephalitis Vaccines Annual Revenue by Company (2020-2025)
3.2.1 Global Japanese Encephalitis Vaccines Revenue by Company (2020-2025)
3.2.2 Global Japanese Encephalitis Vaccines Revenue Market Share by Company (2020-2025)
3.3 Global Japanese Encephalitis Vaccines Sale Price by Company
3.4 Key Manufacturers Japanese Encephalitis Vaccines Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Japanese Encephalitis Vaccines Product Location Distribution
3.4.2 Players Japanese Encephalitis Vaccines Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR JAPANESE ENCEPHALITIS VACCINES BY GEOGRAPHIC REGION
4.1 World Historic Japanese Encephalitis Vaccines Market Size by Geographic Region (2020-2025)
4.1.1 Global Japanese Encephalitis Vaccines Annual Sales by Geographic Region (2020-2025)
4.1.2 Global Japanese Encephalitis Vaccines Annual Revenue by Geographic Region (2020-2025)
4.2 World Historic Japanese Encephalitis Vaccines Market Size by Country/Region (2020-2025)
4.2.1 Global Japanese Encephalitis Vaccines Annual Sales by Country/Region (2020-2025)
4.2.2 Global Japanese Encephalitis Vaccines Annual Revenue by Country/Region (2020-2025)
4.3 Americas Japanese Encephalitis Vaccines Sales Growth
4.4 APAC Japanese Encephalitis Vaccines Sales Growth
4.5 Europe Japanese Encephalitis Vaccines Sales Growth
4.6 Middle East & Africa Japanese Encephalitis Vaccines Sales Growth
5 AMERICAS
5.1 Americas Japanese Encephalitis Vaccines Sales by Country
5.1.1 Americas Japanese Encephalitis Vaccines Sales by Country (2020-2025)
5.1.2 Americas Japanese Encephalitis Vaccines Revenue by Country (2020-2025)
5.2 Americas Japanese Encephalitis Vaccines Sales by Type (2020-2025)
5.3 Americas Japanese Encephalitis Vaccines Sales by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Japanese Encephalitis Vaccines Sales by Region
6.1.1 APAC Japanese Encephalitis Vaccines Sales by Region (2020-2025)
6.1.2 APAC Japanese Encephalitis Vaccines Revenue by Region (2020-2025)
6.2 APAC Japanese Encephalitis Vaccines Sales by Type (2020-2025)
6.3 APAC Japanese Encephalitis Vaccines Sales by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Japanese Encephalitis Vaccines by Country
7.1.1 Europe Japanese Encephalitis Vaccines Sales by Country (2020-2025)
7.1.2 Europe Japanese Encephalitis Vaccines Revenue by Country (2020-2025)
7.2 Europe Japanese Encephalitis Vaccines Sales by Type (2020-2025)
7.3 Europe Japanese Encephalitis Vaccines Sales by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Japanese Encephalitis Vaccines by Country
8.1.1 Middle East & Africa Japanese Encephalitis Vaccines Sales by Country (2020-2025)
8.1.2 Middle East & Africa Japanese Encephalitis Vaccines Revenue by Country (2020-2025)
8.2 Middle East & Africa Japanese Encephalitis Vaccines Sales by Type (2020-2025)
8.3 Middle East & Africa Japanese Encephalitis Vaccines Sales by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Japanese Encephalitis Vaccines
10.3 Manufacturing Process Analysis of Japanese Encephalitis Vaccines
10.4 Industry Chain Structure of Japanese Encephalitis Vaccines
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Japanese Encephalitis Vaccines Distributors
11.3 Japanese Encephalitis Vaccines Customer
12 WORLD FORECAST REVIEW FOR JAPANESE ENCEPHALITIS VACCINES BY GEOGRAPHIC REGION
12.1 Global Japanese Encephalitis Vaccines Market Size Forecast by Region
12.1.1 Global Japanese Encephalitis Vaccines Forecast by Region (2026-2031)
12.1.2 Global Japanese Encephalitis Vaccines Annual Revenue Forecast by Region (2026-2031)
12.2 Americas Forecast by Country (2026-2031)
12.3 APAC Forecast by Region (2026-2031)
12.4 Europe Forecast by Country (2026-2031)
12.5 Middle East & Africa Forecast by Country (2026-2031)
12.6 Global Japanese Encephalitis Vaccines Forecast by Type (2026-2031)
12.7 Global Japanese Encephalitis Vaccines Forecast by Application (2026-2031)
13 KEY PLAYERS ANALYSIS
13.1 Sanofi Pasteur
13.1.1 Sanofi Pasteur Company Information
13.1.2 Sanofi Pasteur Japanese Encephalitis Vaccines Product Portfolios and Specifications
13.1.3 Sanofi Pasteur Japanese Encephalitis Vaccines Sales, Revenue, Price and Gross Margin (2020-2025)
13.1.4 Sanofi Pasteur Main Business Overview
13.1.5 Sanofi Pasteur Latest Developments
13.2 GlaxoSmithKline
13.2.1 GlaxoSmithKline Company Information
13.2.2 GlaxoSmithKline Japanese Encephalitis Vaccines Product Portfolios and Specifications
13.2.3 GlaxoSmithKline Japanese Encephalitis Vaccines Sales, Revenue, Price and Gross Margin (2020-2025)
13.2.4 GlaxoSmithKline Main Business Overview
13.2.5 GlaxoSmithKline Latest Developments
13.3 Bharat Biotech
13.3.1 Bharat Biotech Company Information
13.3.2 Bharat Biotech Japanese Encephalitis Vaccines Product Portfolios and Specifications
13.3.3 Bharat Biotech Japanese Encephalitis Vaccines Sales, Revenue, Price and Gross Margin (2020-2025)
13.3.4 Bharat Biotech Main Business Overview
13.3.5 Bharat Biotech Latest Developments
13.4 China National Biotec Group
13.4.1 China National Biotec Group Company Information
13.4.2 China National Biotec Group Japanese Encephalitis Vaccines Product Portfolios and Specifications
13.4.3 China National Biotec Group Japanese Encephalitis Vaccines Sales, Revenue, Price and Gross Margin (2020-2025)
13.4.4 China National Biotec Group Main Business Overview
13.4.5 China National Biotec Group Latest Developments
13.5 Valneva Products
13.5.1 Valneva Products Company Information
13.5.2 Valneva Products Japanese Encephalitis Vaccines Product Portfolios and Specifications
13.5.3 Valneva Products Japanese Encephalitis Vaccines Sales, Revenue, Price and Gross Margin (2020-2025)
13.5.4 Valneva Products Main Business Overview
13.5.5 Valneva Products Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Japanese Encephalitis Vaccines Annual Sales CAGR by Geographic Region (2020, 2024 & 2031) & ($ millions)
Table 2. Japanese Encephalitis Vaccines Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players of Attenuated Vaccines
Table 4. Major Players of Inactivated Vaccines
Table 5. Global Japanese Encephalitis Vaccines Sales by Type (2020-2025) & (K Doses)
Table 6. Global Japanese Encephalitis Vaccines Sales Market Share by Type (2020-2025)
Table 7. Global Japanese Encephalitis Vaccines Revenue by Type (2020-2025) & ($ million)
Table 8. Global Japanese Encephalitis Vaccines Revenue Market Share by Type (2020-2025)
Table 9. Global Japanese Encephalitis Vaccines Sale Price by Type (2020-2025) & (USD/Dose)
Table 10. Global Japanese Encephalitis Vaccines Sale by Application (2020-2025) & (K Doses)
Table 11. Global Japanese Encephalitis Vaccines Sale Market Share by Application (2020-2025)
Table 12. Global Japanese Encephalitis Vaccines Revenue by Application (2020-2025) & ($ million)
Table 13. Global Japanese Encephalitis Vaccines Revenue Market Share by Application (2020-2025)
Table 14. Global Japanese Encephalitis Vaccines Sale Price by Application (2020-2025) & (USD/Dose)
Table 15. Global Japanese Encephalitis Vaccines Sales by Company (2020-2025) & (K Doses)
Table 16. Global Japanese Encephalitis Vaccines Sales Market Share by Company (2020-2025)
Table 17. Global Japanese Encephalitis Vaccines Revenue by Company (2020-2025) & ($ millions)
Table 18. Global Japanese Encephalitis Vaccines Revenue Market Share by Company (2020-2025)
Table 19. Global Japanese Encephalitis Vaccines Sale Price by Company (2020-2025) & (USD/Dose)
Table 20. Key Manufacturers Japanese Encephalitis Vaccines Producing Area Distribution and Sales Area
Table 21. Players Japanese Encephalitis Vaccines Products Offered
Table 22. Japanese Encephalitis Vaccines Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 23. New Products and Potential Entrants
Table 24. Market M&A Activity & Strategy
Table 25. Global Japanese Encephalitis Vaccines Sales by Geographic Region (2020-2025) & (K Doses)
Table 26. Global Japanese Encephalitis Vaccines Sales Market Share Geographic Region (2020-2025)
Table 27. Global Japanese Encephalitis Vaccines Revenue by Geographic Region (2020-2025) & ($ millions)
Table 28. Global Japanese Encephalitis Vaccines Revenue Market Share by Geographic Region (2020-2025)
Table 29. Global Japanese Encephalitis Vaccines Sales by Country/Region (2020-2025) & (K Doses)
Table 30. Global Japanese Encephalitis Vaccines Sales Market Share by Country/Region (2020-2025)
Table 31. Global Japanese Encephalitis Vaccines Revenue by Country/Region (2020-2025) & ($ millions)
Table 32. Global Japanese Encephalitis Vaccines Revenue Market Share by Country/Region (2020-2025)
Table 33. Americas Japanese Encephalitis Vaccines Sales by Country (2020-2025) & (K Doses)
Table 34. Americas Japanese Encephalitis Vaccines Sales Market Share by Country (2020-2025)
Table 35. Americas Japanese Encephalitis Vaccines Revenue by Country (2020-2025) & ($ millions)
Table 36. Americas Japanese Encephalitis Vaccines Sales by Type (2020-2025) & (K Doses)
Table 37. Americas Japanese Encephalitis Vaccines Sales by Application (2020-2025) & (K Doses)
Table 38. APAC Japanese Encephalitis Vaccines Sales by Region (2020-2025) & (K Doses)
Table 39. APAC Japanese Encephalitis Vaccines Sales Market Share by Region (2020-2025)
Table 40. APAC Japanese Encephalitis Vaccines Revenue by Region (2020-2025) & ($ millions)
Table 41. APAC Japanese Encephalitis Vaccines Sales by Type (2020-2025) & (K Doses)
Table 42. APAC Japanese Encephalitis Vaccines Sales by Application (2020-2025) & (K Doses)
Table 43. Europe Japanese Encephalitis Vaccines Sales by Country (2020-2025) & (K Doses)
Table 44. Europe Japanese Encephalitis Vaccines Revenue by Country (2020-2025) & ($ millions)
Table 45. Europe Japanese Encephalitis Vaccines Sales by Type (2020-2025) & (K Doses)
Table 46. Europe Japanese Encephalitis Vaccines Sales by Application (2020-2025) & (K Doses)
Table 47. Middle East & Africa Japanese Encephalitis Vaccines Sales by Country (2020-2025) & (K Doses)
Table 48. Middle East & Africa Japanese Encephalitis Vaccines Revenue Market Share by Country (2020-2025)
Table 49. Middle East & Africa Japanese Encephalitis Vaccines Sales by Type (2020-2025) & (K Doses)
Table 50. Middle East & Africa Japanese Encephalitis Vaccines Sales by Application (2020-2025) & (K Doses)
Table 51. Key Market Drivers & Growth Opportunities of Japanese Encephalitis Vaccines
Table 52. Key Market Challenges & Risks of Japanese Encephalitis Vaccines
Table 53. Key Industry Trends of Japanese Encephalitis Vaccines
Table 54. Japanese Encephalitis Vaccines Raw Material
Table 55. Key Suppliers of Raw Materials
Table 56. Japanese Encephalitis Vaccines Distributors List
Table 57. Japanese Encephalitis Vaccines Customer List
Table 58. Global Japanese Encephalitis Vaccines Sales Forecast by Region (2026-2031) & (K Doses)
Table 59. Global Japanese Encephalitis Vaccines Revenue Forecast by Region (2026-2031) & ($ millions)
Table 60. Americas Japanese Encephalitis Vaccines Sales Forecast by Country (2026-2031) & (K Doses)
Table 61. Americas Japanese Encephalitis Vaccines Annual Revenue Forecast by Country (2026-2031) & ($ millions)
Table 62. APAC Japanese Encephalitis Vaccines Sales Forecast by Region (2026-2031) & (K Doses)
Table 63. APAC Japanese Encephalitis Vaccines Annual Revenue Forecast by Region (2026-2031) & ($ millions)
Table 64. Europe Japanese Encephalitis Vaccines Sales Forecast by Country (2026-2031) & (K Doses)
Table 65. Europe Japanese Encephalitis Vaccines Revenue Forecast by Country (2026-2031) & ($ millions)
Table 66. Middle East & Africa Japanese Encephalitis Vaccines Sales Forecast by Country (2026-2031) & (K Doses)
Table 67. Middle East & Africa Japanese Encephalitis Vaccines Revenue Forecast by Country (2026-2031) & ($ millions)
Table 68. Global Japanese Encephalitis Vaccines Sales Forecast by Type (2026-2031) & (K Doses)
Table 69. Global Japanese Encephalitis Vaccines Revenue Forecast by Type (2026-2031) & ($ millions)
Table 70. Global Japanese Encephalitis Vaccines Sales Forecast by Application (2026-2031) & (K Doses)
Table 71. Global Japanese Encephalitis Vaccines Revenue Forecast by Application (2026-2031) & ($ millions)
Table 72. Sanofi Pasteur Basic Information, Japanese Encephalitis Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 73. Sanofi Pasteur Japanese Encephalitis Vaccines Product Portfolios and Specifications
Table 74. Sanofi Pasteur Japanese Encephalitis Vaccines Sales (K Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2020-2025)
Table 75. Sanofi Pasteur Main Business
Table 76. Sanofi Pasteur Latest Developments
Table 77. GlaxoSmithKline Basic Information, Japanese Encephalitis Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 78. GlaxoSmithKline Japanese Encephalitis Vaccines Product Portfolios and Specifications
Table 79. GlaxoSmithKline Japanese Encephalitis Vaccines Sales (K Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2020-2025)
Table 80. GlaxoSmithKline Main Business
Table 81. GlaxoSmithKline Latest Developments
Table 82. Bharat Biotech Basic Information, Japanese Encephalitis Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 83. Bharat Biotech Japanese Encephalitis Vaccines Product Portfolios and Specifications
Table 84. Bharat Biotech Japanese Encephalitis Vaccines Sales (K Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2020-2025)
Table 85. Bharat Biotech Main Business
Table 86. Bharat Biotech Latest Developments
Table 87. China National Biotec Group Basic Information, Japanese Encephalitis Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 88. China National Biotec Group Japanese Encephalitis Vaccines Product Portfolios and Specifications
Table 89. China National Biotec Group Japanese Encephalitis Vaccines Sales (K Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2020-2025)
Table 90. China National Biotec Group Main Business
Table 91. China National Biotec Group Latest Developments
Table 92. Valneva Products Basic Information, Japanese Encephalitis Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 93. Valneva Products Japanese Encephalitis Vaccines Product Portfolios and Specifications
Table 94. Valneva Products Japanese Encephalitis Vaccines Sales (K Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2020-2025)
Table 95. Valneva Products Main Business
Table 96. Valneva Products Latest Developments
Table 1. Japanese Encephalitis Vaccines Annual Sales CAGR by Geographic Region (2020, 2024 & 2031) & ($ millions)
Table 2. Japanese Encephalitis Vaccines Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players of Attenuated Vaccines
Table 4. Major Players of Inactivated Vaccines
Table 5. Global Japanese Encephalitis Vaccines Sales by Type (2020-2025) & (K Doses)
Table 6. Global Japanese Encephalitis Vaccines Sales Market Share by Type (2020-2025)
Table 7. Global Japanese Encephalitis Vaccines Revenue by Type (2020-2025) & ($ million)
Table 8. Global Japanese Encephalitis Vaccines Revenue Market Share by Type (2020-2025)
Table 9. Global Japanese Encephalitis Vaccines Sale Price by Type (2020-2025) & (USD/Dose)
Table 10. Global Japanese Encephalitis Vaccines Sale by Application (2020-2025) & (K Doses)
Table 11. Global Japanese Encephalitis Vaccines Sale Market Share by Application (2020-2025)
Table 12. Global Japanese Encephalitis Vaccines Revenue by Application (2020-2025) & ($ million)
Table 13. Global Japanese Encephalitis Vaccines Revenue Market Share by Application (2020-2025)
Table 14. Global Japanese Encephalitis Vaccines Sale Price by Application (2020-2025) & (USD/Dose)
Table 15. Global Japanese Encephalitis Vaccines Sales by Company (2020-2025) & (K Doses)
Table 16. Global Japanese Encephalitis Vaccines Sales Market Share by Company (2020-2025)
Table 17. Global Japanese Encephalitis Vaccines Revenue by Company (2020-2025) & ($ millions)
Table 18. Global Japanese Encephalitis Vaccines Revenue Market Share by Company (2020-2025)
Table 19. Global Japanese Encephalitis Vaccines Sale Price by Company (2020-2025) & (USD/Dose)
Table 20. Key Manufacturers Japanese Encephalitis Vaccines Producing Area Distribution and Sales Area
Table 21. Players Japanese Encephalitis Vaccines Products Offered
Table 22. Japanese Encephalitis Vaccines Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 23. New Products and Potential Entrants
Table 24. Market M&A Activity & Strategy
Table 25. Global Japanese Encephalitis Vaccines Sales by Geographic Region (2020-2025) & (K Doses)
Table 26. Global Japanese Encephalitis Vaccines Sales Market Share Geographic Region (2020-2025)
Table 27. Global Japanese Encephalitis Vaccines Revenue by Geographic Region (2020-2025) & ($ millions)
Table 28. Global Japanese Encephalitis Vaccines Revenue Market Share by Geographic Region (2020-2025)
Table 29. Global Japanese Encephalitis Vaccines Sales by Country/Region (2020-2025) & (K Doses)
Table 30. Global Japanese Encephalitis Vaccines Sales Market Share by Country/Region (2020-2025)
Table 31. Global Japanese Encephalitis Vaccines Revenue by Country/Region (2020-2025) & ($ millions)
Table 32. Global Japanese Encephalitis Vaccines Revenue Market Share by Country/Region (2020-2025)
Table 33. Americas Japanese Encephalitis Vaccines Sales by Country (2020-2025) & (K Doses)
Table 34. Americas Japanese Encephalitis Vaccines Sales Market Share by Country (2020-2025)
Table 35. Americas Japanese Encephalitis Vaccines Revenue by Country (2020-2025) & ($ millions)
Table 36. Americas Japanese Encephalitis Vaccines Sales by Type (2020-2025) & (K Doses)
Table 37. Americas Japanese Encephalitis Vaccines Sales by Application (2020-2025) & (K Doses)
Table 38. APAC Japanese Encephalitis Vaccines Sales by Region (2020-2025) & (K Doses)
Table 39. APAC Japanese Encephalitis Vaccines Sales Market Share by Region (2020-2025)
Table 40. APAC Japanese Encephalitis Vaccines Revenue by Region (2020-2025) & ($ millions)
Table 41. APAC Japanese Encephalitis Vaccines Sales by Type (2020-2025) & (K Doses)
Table 42. APAC Japanese Encephalitis Vaccines Sales by Application (2020-2025) & (K Doses)
Table 43. Europe Japanese Encephalitis Vaccines Sales by Country (2020-2025) & (K Doses)
Table 44. Europe Japanese Encephalitis Vaccines Revenue by Country (2020-2025) & ($ millions)
Table 45. Europe Japanese Encephalitis Vaccines Sales by Type (2020-2025) & (K Doses)
Table 46. Europe Japanese Encephalitis Vaccines Sales by Application (2020-2025) & (K Doses)
Table 47. Middle East & Africa Japanese Encephalitis Vaccines Sales by Country (2020-2025) & (K Doses)
Table 48. Middle East & Africa Japanese Encephalitis Vaccines Revenue Market Share by Country (2020-2025)
Table 49. Middle East & Africa Japanese Encephalitis Vaccines Sales by Type (2020-2025) & (K Doses)
Table 50. Middle East & Africa Japanese Encephalitis Vaccines Sales by Application (2020-2025) & (K Doses)
Table 51. Key Market Drivers & Growth Opportunities of Japanese Encephalitis Vaccines
Table 52. Key Market Challenges & Risks of Japanese Encephalitis Vaccines
Table 53. Key Industry Trends of Japanese Encephalitis Vaccines
Table 54. Japanese Encephalitis Vaccines Raw Material
Table 55. Key Suppliers of Raw Materials
Table 56. Japanese Encephalitis Vaccines Distributors List
Table 57. Japanese Encephalitis Vaccines Customer List
Table 58. Global Japanese Encephalitis Vaccines Sales Forecast by Region (2026-2031) & (K Doses)
Table 59. Global Japanese Encephalitis Vaccines Revenue Forecast by Region (2026-2031) & ($ millions)
Table 60. Americas Japanese Encephalitis Vaccines Sales Forecast by Country (2026-2031) & (K Doses)
Table 61. Americas Japanese Encephalitis Vaccines Annual Revenue Forecast by Country (2026-2031) & ($ millions)
Table 62. APAC Japanese Encephalitis Vaccines Sales Forecast by Region (2026-2031) & (K Doses)
Table 63. APAC Japanese Encephalitis Vaccines Annual Revenue Forecast by Region (2026-2031) & ($ millions)
Table 64. Europe Japanese Encephalitis Vaccines Sales Forecast by Country (2026-2031) & (K Doses)
Table 65. Europe Japanese Encephalitis Vaccines Revenue Forecast by Country (2026-2031) & ($ millions)
Table 66. Middle East & Africa Japanese Encephalitis Vaccines Sales Forecast by Country (2026-2031) & (K Doses)
Table 67. Middle East & Africa Japanese Encephalitis Vaccines Revenue Forecast by Country (2026-2031) & ($ millions)
Table 68. Global Japanese Encephalitis Vaccines Sales Forecast by Type (2026-2031) & (K Doses)
Table 69. Global Japanese Encephalitis Vaccines Revenue Forecast by Type (2026-2031) & ($ millions)
Table 70. Global Japanese Encephalitis Vaccines Sales Forecast by Application (2026-2031) & (K Doses)
Table 71. Global Japanese Encephalitis Vaccines Revenue Forecast by Application (2026-2031) & ($ millions)
Table 72. Sanofi Pasteur Basic Information, Japanese Encephalitis Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 73. Sanofi Pasteur Japanese Encephalitis Vaccines Product Portfolios and Specifications
Table 74. Sanofi Pasteur Japanese Encephalitis Vaccines Sales (K Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2020-2025)
Table 75. Sanofi Pasteur Main Business
Table 76. Sanofi Pasteur Latest Developments
Table 77. GlaxoSmithKline Basic Information, Japanese Encephalitis Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 78. GlaxoSmithKline Japanese Encephalitis Vaccines Product Portfolios and Specifications
Table 79. GlaxoSmithKline Japanese Encephalitis Vaccines Sales (K Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2020-2025)
Table 80. GlaxoSmithKline Main Business
Table 81. GlaxoSmithKline Latest Developments
Table 82. Bharat Biotech Basic Information, Japanese Encephalitis Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 83. Bharat Biotech Japanese Encephalitis Vaccines Product Portfolios and Specifications
Table 84. Bharat Biotech Japanese Encephalitis Vaccines Sales (K Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2020-2025)
Table 85. Bharat Biotech Main Business
Table 86. Bharat Biotech Latest Developments
Table 87. China National Biotec Group Basic Information, Japanese Encephalitis Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 88. China National Biotec Group Japanese Encephalitis Vaccines Product Portfolios and Specifications
Table 89. China National Biotec Group Japanese Encephalitis Vaccines Sales (K Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2020-2025)
Table 90. China National Biotec Group Main Business
Table 91. China National Biotec Group Latest Developments
Table 92. Valneva Products Basic Information, Japanese Encephalitis Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 93. Valneva Products Japanese Encephalitis Vaccines Product Portfolios and Specifications
Table 94. Valneva Products Japanese Encephalitis Vaccines Sales (K Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2020-2025)
Table 95. Valneva Products Main Business
Table 96. Valneva Products Latest Developments
LIST OF FIGURES
Figure 1. Picture of Japanese Encephalitis Vaccines
Figure 2. Japanese Encephalitis Vaccines Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Japanese Encephalitis Vaccines Sales Growth Rate 2020-2031 (K Doses)
Figure 7. Global Japanese Encephalitis Vaccines Revenue Growth Rate 2020-2031 ($ millions)
Figure 8. Japanese Encephalitis Vaccines Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
Figure 9. Japanese Encephalitis Vaccines Sales Market Share by Country/Region (2024)
Figure 10. Japanese Encephalitis Vaccines Sales Market Share by Country/Region (2020, 2024 & 2031)
Figure 11. Product Picture of Attenuated Vaccines
Figure 12. Product Picture of Inactivated Vaccines
Figure 13. Global Japanese Encephalitis Vaccines Sales Market Share by Type in 2025
Figure 14. Global Japanese Encephalitis Vaccines Revenue Market Share by Type (2020-2025)
Figure 15. Japanese Encephalitis Vaccines Consumed in Adults
Figure 16. Global Japanese Encephalitis Vaccines Market: Adults (2020-2025) & (K Doses)
Figure 17. Japanese Encephalitis Vaccines Consumed in Children
Figure 18. Global Japanese Encephalitis Vaccines Market: Children (2020-2025) & (K Doses)
Figure 19. Global Japanese Encephalitis Vaccines Sale Market Share by Application (2024)
Figure 20. Global Japanese Encephalitis Vaccines Revenue Market Share by Application in 2025
Figure 21. Japanese Encephalitis Vaccines Sales by Company in 2025 (K Doses)
Figure 22. Global Japanese Encephalitis Vaccines Sales Market Share by Company in 2025
Figure 23. Japanese Encephalitis Vaccines Revenue by Company in 2025 ($ millions)
Figure 24. Global Japanese Encephalitis Vaccines Revenue Market Share by Company in 2025
Figure 25. Global Japanese Encephalitis Vaccines Sales Market Share by Geographic Region (2020-2025)
Figure 26. Global Japanese Encephalitis Vaccines Revenue Market Share by Geographic Region in 2025
Figure 27. Americas Japanese Encephalitis Vaccines Sales 2020-2025 (K Doses)
Figure 28. Americas Japanese Encephalitis Vaccines Revenue 2020-2025 ($ millions)
Figure 29. APAC Japanese Encephalitis Vaccines Sales 2020-2025 (K Doses)
Figure 30. APAC Japanese Encephalitis Vaccines Revenue 2020-2025 ($ millions)
Figure 31. Europe Japanese Encephalitis Vaccines Sales 2020-2025 (K Doses)
Figure 32. Europe Japanese Encephalitis Vaccines Revenue 2020-2025 ($ millions)
Figure 33. Middle East & Africa Japanese Encephalitis Vaccines Sales 2020-2025 (K Doses)
Figure 34. Middle East & Africa Japanese Encephalitis Vaccines Revenue 2020-2025 ($ millions)
Figure 35. Americas Japanese Encephalitis Vaccines Sales Market Share by Country in 2025
Figure 36. Americas Japanese Encephalitis Vaccines Revenue Market Share by Country (2020-2025)
Figure 37. Americas Japanese Encephalitis Vaccines Sales Market Share by Type (2020-2025)
Figure 38. Americas Japanese Encephalitis Vaccines Sales Market Share by Application (2020-2025)
Figure 39. United States Japanese Encephalitis Vaccines Revenue Growth 2020-2025 ($ millions)
Figure 40. Canada Japanese Encephalitis Vaccines Revenue Growth 2020-2025 ($ millions)
Figure 41. Mexico Japanese Encephalitis Vaccines Revenue Growth 2020-2025 ($ millions)
Figure 42. Brazil Japanese Encephalitis Vaccines Revenue Growth 2020-2025 ($ millions)
Figure 43. APAC Japanese Encephalitis Vaccines Sales Market Share by Region in 2025
Figure 44. APAC Japanese Encephalitis Vaccines Revenue Market Share by Region (2020-2025)
Figure 45. APAC Japanese Encephalitis Vaccines Sales Market Share by Type (2020-2025)
Figure 46. APAC Japanese Encephalitis Vaccines Sales Market Share by Application (2020-2025)
Figure 47. China Japanese Encephalitis Vaccines Revenue Growth 2020-2025 ($ millions)
Figure 48. Japan Japanese Encephalitis Vaccines Revenue Growth 2020-2025 ($ millions)
Figure 49. South Korea Japanese Encephalitis Vaccines Revenue Growth 2020-2025 ($ millions)
Figure 50. Southeast Asia Japanese Encephalitis Vaccines Revenue Growth 2020-2025 ($ millions)
Figure 51. India Japanese Encephalitis Vaccines Revenue Growth 2020-2025 ($ millions)
Figure 52. Australia Japanese Encephalitis Vaccines Revenue Growth 2020-2025 ($ millions)
Figure 53. China Taiwan Japanese Encephalitis Vaccines Revenue Growth 2020-2025 ($ millions)
Figure 54. Europe Japanese Encephalitis Vaccines Sales Market Share by Country in 2025
Figure 55. Europe Japanese Encephalitis Vaccines Revenue Market Share by Country (2020-2025)
Figure 56. Europe Japanese Encephalitis Vaccines Sales Market Share by Type (2020-2025)
Figure 57. Europe Japanese Encephalitis Vaccines Sales Market Share by Application (2020-2025)
Figure 58. Germany Japanese Encephalitis Vaccines Revenue Growth 2020-2025 ($ millions)
Figure 59. France Japanese Encephalitis Vaccines Revenue Growth 2020-2025 ($ millions)
Figure 60. UK Japanese Encephalitis Vaccines Revenue Growth 2020-2025 ($ millions)
Figure 61. Italy Japanese Encephalitis Vaccines Revenue Growth 2020-2025 ($ millions)
Figure 62. Russia Japanese Encephalitis Vaccines Revenue Growth 2020-2025 ($ millions)
Figure 63. Middle East & Africa Japanese Encephalitis Vaccines Sales Market Share by Country (2020-2025)
Figure 64. Middle East & Africa Japanese Encephalitis Vaccines Sales Market Share by Type (2020-2025)
Figure 65. Middle East & Africa Japanese Encephalitis Vaccines Sales Market Share by Application (2020-2025)
Figure 66. Egypt Japanese Encephalitis Vaccines Revenue Growth 2020-2025 ($ millions)
Figure 67. South Africa Japanese Encephalitis Vaccines Revenue Growth 2020-2025 ($ millions)
Figure 68. Israel Japanese Encephalitis Vaccines Revenue Growth 2020-2025 ($ millions)
Figure 69. Turkey Japanese Encephalitis Vaccines Revenue Growth 2020-2025 ($ millions)
Figure 70. GCC Countries Japanese Encephalitis Vaccines Revenue Growth 2020-2025 ($ millions)
Figure 71. Manufacturing Cost Structure Analysis of Japanese Encephalitis Vaccines in 2025
Figure 72. Manufacturing Process Analysis of Japanese Encephalitis Vaccines
Figure 73. Industry Chain Structure of Japanese Encephalitis Vaccines
Figure 74. Channels of Distribution
Figure 75. Global Japanese Encephalitis Vaccines Sales Market Forecast by Region (2026-2031)
Figure 76. Global Japanese Encephalitis Vaccines Revenue Market Share Forecast by Region (2026-2031)
Figure 77. Global Japanese Encephalitis Vaccines Sales Market Share Forecast by Type (2026-2031)
Figure 78. Global Japanese Encephalitis Vaccines Revenue Market Share Forecast by Type (2026-2031)
Figure 79. Global Japanese Encephalitis Vaccines Sales Market Share Forecast by Application (2026-2031)
Figure 80. Global Japanese Encephalitis Vaccines Revenue Market Share Forecast by Application (2026-2031)
Figure 1. Picture of Japanese Encephalitis Vaccines
Figure 2. Japanese Encephalitis Vaccines Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Japanese Encephalitis Vaccines Sales Growth Rate 2020-2031 (K Doses)
Figure 7. Global Japanese Encephalitis Vaccines Revenue Growth Rate 2020-2031 ($ millions)
Figure 8. Japanese Encephalitis Vaccines Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
Figure 9. Japanese Encephalitis Vaccines Sales Market Share by Country/Region (2024)
Figure 10. Japanese Encephalitis Vaccines Sales Market Share by Country/Region (2020, 2024 & 2031)
Figure 11. Product Picture of Attenuated Vaccines
Figure 12. Product Picture of Inactivated Vaccines
Figure 13. Global Japanese Encephalitis Vaccines Sales Market Share by Type in 2025
Figure 14. Global Japanese Encephalitis Vaccines Revenue Market Share by Type (2020-2025)
Figure 15. Japanese Encephalitis Vaccines Consumed in Adults
Figure 16. Global Japanese Encephalitis Vaccines Market: Adults (2020-2025) & (K Doses)
Figure 17. Japanese Encephalitis Vaccines Consumed in Children
Figure 18. Global Japanese Encephalitis Vaccines Market: Children (2020-2025) & (K Doses)
Figure 19. Global Japanese Encephalitis Vaccines Sale Market Share by Application (2024)
Figure 20. Global Japanese Encephalitis Vaccines Revenue Market Share by Application in 2025
Figure 21. Japanese Encephalitis Vaccines Sales by Company in 2025 (K Doses)
Figure 22. Global Japanese Encephalitis Vaccines Sales Market Share by Company in 2025
Figure 23. Japanese Encephalitis Vaccines Revenue by Company in 2025 ($ millions)
Figure 24. Global Japanese Encephalitis Vaccines Revenue Market Share by Company in 2025
Figure 25. Global Japanese Encephalitis Vaccines Sales Market Share by Geographic Region (2020-2025)
Figure 26. Global Japanese Encephalitis Vaccines Revenue Market Share by Geographic Region in 2025
Figure 27. Americas Japanese Encephalitis Vaccines Sales 2020-2025 (K Doses)
Figure 28. Americas Japanese Encephalitis Vaccines Revenue 2020-2025 ($ millions)
Figure 29. APAC Japanese Encephalitis Vaccines Sales 2020-2025 (K Doses)
Figure 30. APAC Japanese Encephalitis Vaccines Revenue 2020-2025 ($ millions)
Figure 31. Europe Japanese Encephalitis Vaccines Sales 2020-2025 (K Doses)
Figure 32. Europe Japanese Encephalitis Vaccines Revenue 2020-2025 ($ millions)
Figure 33. Middle East & Africa Japanese Encephalitis Vaccines Sales 2020-2025 (K Doses)
Figure 34. Middle East & Africa Japanese Encephalitis Vaccines Revenue 2020-2025 ($ millions)
Figure 35. Americas Japanese Encephalitis Vaccines Sales Market Share by Country in 2025
Figure 36. Americas Japanese Encephalitis Vaccines Revenue Market Share by Country (2020-2025)
Figure 37. Americas Japanese Encephalitis Vaccines Sales Market Share by Type (2020-2025)
Figure 38. Americas Japanese Encephalitis Vaccines Sales Market Share by Application (2020-2025)
Figure 39. United States Japanese Encephalitis Vaccines Revenue Growth 2020-2025 ($ millions)
Figure 40. Canada Japanese Encephalitis Vaccines Revenue Growth 2020-2025 ($ millions)
Figure 41. Mexico Japanese Encephalitis Vaccines Revenue Growth 2020-2025 ($ millions)
Figure 42. Brazil Japanese Encephalitis Vaccines Revenue Growth 2020-2025 ($ millions)
Figure 43. APAC Japanese Encephalitis Vaccines Sales Market Share by Region in 2025
Figure 44. APAC Japanese Encephalitis Vaccines Revenue Market Share by Region (2020-2025)
Figure 45. APAC Japanese Encephalitis Vaccines Sales Market Share by Type (2020-2025)
Figure 46. APAC Japanese Encephalitis Vaccines Sales Market Share by Application (2020-2025)
Figure 47. China Japanese Encephalitis Vaccines Revenue Growth 2020-2025 ($ millions)
Figure 48. Japan Japanese Encephalitis Vaccines Revenue Growth 2020-2025 ($ millions)
Figure 49. South Korea Japanese Encephalitis Vaccines Revenue Growth 2020-2025 ($ millions)
Figure 50. Southeast Asia Japanese Encephalitis Vaccines Revenue Growth 2020-2025 ($ millions)
Figure 51. India Japanese Encephalitis Vaccines Revenue Growth 2020-2025 ($ millions)
Figure 52. Australia Japanese Encephalitis Vaccines Revenue Growth 2020-2025 ($ millions)
Figure 53. China Taiwan Japanese Encephalitis Vaccines Revenue Growth 2020-2025 ($ millions)
Figure 54. Europe Japanese Encephalitis Vaccines Sales Market Share by Country in 2025
Figure 55. Europe Japanese Encephalitis Vaccines Revenue Market Share by Country (2020-2025)
Figure 56. Europe Japanese Encephalitis Vaccines Sales Market Share by Type (2020-2025)
Figure 57. Europe Japanese Encephalitis Vaccines Sales Market Share by Application (2020-2025)
Figure 58. Germany Japanese Encephalitis Vaccines Revenue Growth 2020-2025 ($ millions)
Figure 59. France Japanese Encephalitis Vaccines Revenue Growth 2020-2025 ($ millions)
Figure 60. UK Japanese Encephalitis Vaccines Revenue Growth 2020-2025 ($ millions)
Figure 61. Italy Japanese Encephalitis Vaccines Revenue Growth 2020-2025 ($ millions)
Figure 62. Russia Japanese Encephalitis Vaccines Revenue Growth 2020-2025 ($ millions)
Figure 63. Middle East & Africa Japanese Encephalitis Vaccines Sales Market Share by Country (2020-2025)
Figure 64. Middle East & Africa Japanese Encephalitis Vaccines Sales Market Share by Type (2020-2025)
Figure 65. Middle East & Africa Japanese Encephalitis Vaccines Sales Market Share by Application (2020-2025)
Figure 66. Egypt Japanese Encephalitis Vaccines Revenue Growth 2020-2025 ($ millions)
Figure 67. South Africa Japanese Encephalitis Vaccines Revenue Growth 2020-2025 ($ millions)
Figure 68. Israel Japanese Encephalitis Vaccines Revenue Growth 2020-2025 ($ millions)
Figure 69. Turkey Japanese Encephalitis Vaccines Revenue Growth 2020-2025 ($ millions)
Figure 70. GCC Countries Japanese Encephalitis Vaccines Revenue Growth 2020-2025 ($ millions)
Figure 71. Manufacturing Cost Structure Analysis of Japanese Encephalitis Vaccines in 2025
Figure 72. Manufacturing Process Analysis of Japanese Encephalitis Vaccines
Figure 73. Industry Chain Structure of Japanese Encephalitis Vaccines
Figure 74. Channels of Distribution
Figure 75. Global Japanese Encephalitis Vaccines Sales Market Forecast by Region (2026-2031)
Figure 76. Global Japanese Encephalitis Vaccines Revenue Market Share Forecast by Region (2026-2031)
Figure 77. Global Japanese Encephalitis Vaccines Sales Market Share Forecast by Type (2026-2031)
Figure 78. Global Japanese Encephalitis Vaccines Revenue Market Share Forecast by Type (2026-2031)
Figure 79. Global Japanese Encephalitis Vaccines Sales Market Share Forecast by Application (2026-2031)
Figure 80. Global Japanese Encephalitis Vaccines Revenue Market Share Forecast by Application (2026-2031)
More Publications
Global Cryotherapy Market Growth (Status and Outlook) 2025-2031
US$ 3,660.00
January 2025
135 pages
Global Polycystic Ovarian Syndrome (PCOS) Therapeutics Market Growth (Status and Outlook) 2025-2031
US$ 3,660.00
September 2025
82 pages
Global Chemotherapy Induced Peripheral Neuropathy Treatment Market Growth 2025-2031
US$ 3,660.00
March 2025
118 pages
